x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Proactive - Interviews for investors

Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage. Here we plug you into what’s new and exciting in the world of business.

business investing

All Episodes

00:04:20

Tonix licenses global rights to novel non-opioid...

Proactive - Interviews for investors ·

2025/12/24

Tonix Pharmaceuticals Holdings CEO Dr. Seth Lederman joined Steve Darling from Proactive to announce that the company has secured exclusive worldwide licensing rights to TNX-4900, a highly selective small-molecule Sigma-1 receptor (S1R) antagonist with demonstrated analgesic activity across multiple preclinical models of neuropathic pain. Lederman explained that Sigma-1 receptor antagonism has attracted growing scientific and clinical interest as a promising new class of non-opioid, non-addictive

en

00:04:13

Arrow Exploration brings Mateguafa HZ7 well online,...

Proactive - Interviews for investors ·

2025/12/24

Arrow Exploration CEO Marshall Abbott joined Steve Darling from Proactive to provide an operational update on activity at the Mateguafa Attic field, located on the Tapir Block in Colombia’s prolific Llanos Basin, where Arrow holds a 50% beneficial interest. The update highlighted the successful drilling, completion, and initial production performance of the Mateguafa HZ7 (M-HZ7) horizontal well. Abbott confirmed that the M-HZ7 well was spud on November 22, 2025, and reached its target depth on

en

00:04:40

U.S. Gold raises $31.2M in private placement to...

Proactive - Interviews for investors ·

2025/12/24

U.S. Gold Corp. Chairman Luke Norman joined Steve Darling from Proactive to provide an update on the company’s financing activities following the successful closing of a private placement that raised approximately $31.2 million in gross proceeds. The financing represents a significant step forward as the company advances toward development of its flagship CK Gold Project in Wyoming. Norman explained that the offering was priced based on the closing price of U.S. Gold’s common shares on Monday,

en

00:05:58

GMG secures EPA approval milestone for THERMAL-XR®...

Proactive - Interviews for investors ·

2025/12/23

Graphene Manufacturing Group CEO Craig Nicol joined Steve Darling from Proactive to provide an update on the company’s commercialisation progress, highlighting a major regulatory milestone for its THERMAL-XR® ENHANCE graphene coating product. GMG announced it has received and accepted the United States Environmental Protection Agency’s consent notice approval conditions under the Pre-Manufacture Notice (PMN) process, clearing an important step toward full market entry in the United States. The EPA

en

00:04:19

Medicus Pharma partners With Reliant AI to advance...

Proactive - Interviews for investors ·

2025/12/23

Medicus Pharma Chief Medical Officer Dr. Faisel Mehmud joined Steve Darling from Proactive to announce that the company has entered into a non-binding letter of intent with Reliant AI, a decision-intelligence company specializing in generative artificial intelligence for the life sciences. The proposed collaboration is focused on developing an AI-powered data analytics platform designed to enhance clinical trial execution through advanced, data-driven insights. Reliant AI is a privately held

en

00:05:21

Nextech3D.ai confirms Krafty Labs acquisition aet to...

Proactive - Interviews for investors ·

2025/12/23

Nextech3D.ai CEO Evan Gappelberg joined Steve Darling from Proactive to announce that the company has successfully completed its due diligence process and is preparing to close its acquisition of Krafty Labs on January 2, 2026, subject to customary closing conditions, including approval from the Canadian Securities Exchange (CSE). Gappelberg explained that Krafty Labs brings a highly attractive blue-chip customer roster that includes global technology and enterprise leaders such as Google,

en

00:02:32

Helix eyes first helium output at Rudyard with PSA...

Proactive - Interviews for investors ·

2025/12/23

HeLIX Exploration PLC (AIM:HEX, OTCQB:HHEXF) CEO Bo Sears talked with Proactive's Stephen Gunnion about the company’s imminent transition into helium production at its Rudyard project in Montana. Sears confirmed that the PSA compressor, described as the "long lead item," is now en route to site, marking the final step in completing the processing unit. “Once that is delivered and installed, we will be a helium producing company,” Sears told Proactive, emphasizing that all other infrastructure is

en

00:05:52

Oakmount & Partners investee Intergroup Mining moves...

Proactive - Interviews for investors ·

2025/12/22

Oakmount & Partners Ltd managing director Glenn King talked with Proactive's Stephen Gunnion about the progress investee company Intergroup Mining has made toward its planned listing on the Nasdaq stock exchange. King explained that the submission of legal and accounting documentation to the US Securities and Exchange Commission (SEC) marks a “significant milestone” for Intergroup Mining. “It now means that the company, from a tangible perspective, is just one stage closer to its debut listing,” he

en

00:02:59

Frontier IP investee Dekiln secures £3m for...

Proactive - Interviews for investors ·

2025/12/22

Dekiln CEO Dr Aled Roberts talked with Proactive's Stephen Gunnion about the company’s breakthrough in sustainable ceramic tile production and how £3 million in funding from the Royal Academy of Engineering’s Green Future Fellowship program will help scale the technology. Roberts explained that conventional ceramic tiles have a high carbon footprint due to the energy-intensive kiln-firing process. Dekiln has developed an alternative by mimicking natural processes seen in seashells and tooth enamel,

en

00:03:49

M2i Global advances Volato merger and updates...

Proactive - Interviews for investors ·

2025/12/19

M2i Global CEO Alberto Rosende joined Steve Darling from Proactive to provide an update on the company’s strategic initiatives, including progress on its merger with Volato and a new offtake agreement with Next-Gen.Rosende confirmed that the long-anticipated merger with Volato is moving forward after delays caused by a recent government shutdown. “We were able to push it out quickly,” he said, referencing the company’s SEC filing response. The shareholder meeting to approve the merger is scheduled

en

00:05:08

Replenish Nutrients moves into commercialization with...

Proactive - Interviews for investors ·

2025/12/19

Replenish Nutrients CEO Neil Wiens joined Steve Darling to outline the company’s transition from development into full commercialization, highlighted by strategic licensing agreements and a significant partnership in the United States.Wiens described 2025 as a pivotal transformation year for Replenish Nutrients. During this period, the company successfully completed its proof-of-concept phase, finalized key intellectual property filings, and moved into commercial-scale operations. “We are

en

00:05:59

ProPhase Labs announces LOI for reverse merger with...

Proactive - Interviews for investors ·

2025/12/19

ProPhase Labs CEO Ted Karkus joined Steve Darling from Proactive to announce that the company has entered into a non-binding Letter of Intent (LOI) regarding a proposed reverse merger transaction with Advanced Biological Laboratories (ABL), a European biotechnology and MedTech group. Under the proposed structure, Advanced Biological would become the majority owner of the combined public entity, while ProPhase’s existing operations would continue as sister companies to a newly formed U.S

en

00:05:09

Cabbacis prepares for U.S. launch of low-nicotine...

Proactive - Interviews for investors ·

2025/12/19

Cabbacis CEO Joe Pandolfino joined Steve Darling from to discuss the company’s strategic preparations to enter the U.S. market with its proprietary low-nicotine tobacco products. Cabbacis is a federally licensed tobacco product manufacturer with a robust intellectual property portfolio that includes 35 issued patents worldwide, covering its iBlend™ cigarettes and vaporizer pod technology. The company operates out of a manufacturing facility in Niagara Falls, New York, and is led by a management team

en

00:03:42

Happy Creek reports strong Tungsten assays from 2025...

Proactive - Interviews for investors ·

2025/12/18

Happy Creek Minerals CEO Steve Gray joined Steve Darling from Proactive to share details of the company’s latest assay results from its 2025 diamond drilling program at the Fox Tungsten Project in British Columbia. The recently completed program focused on expanding the known tungsten mineralization at the Ridley Creek (RC) and BN zones, two of the project’s most prospective target areas. During September and October, Happy Creek completed a total of 18 diamond core drill holes at the Fox Project,

en

00:03:40

Ilika begins shipping Stereax M300 prototypes,...

Proactive - Interviews for investors ·

2025/12/18

Ilika CEO Graeme Purdy joined Steve Darling from Proactive to announce that the company has begun shipping prototype Stereax M300 solid-state batteries to customers, marking a significant commercial milestone for the business. The initial shipments represent the first delivery of the M300 product and will be allocated to the 21 customers that currently make up Ilika’s existing order book.Many of these customers have already evaluated earlier-generation Stereax batteries supplied from Ilika’s UK

en

00:07:35

Skyler Weinand on rate cuts and bond strategies

Proactive - Interviews for investors ·

2025/12/17

Regan Capital CIO Skyler Weinand joined Steve Darling from Proactive to share news about the dynamics of the fixed income markets, interest rates, and mortgage-backed securities.Weinand outlined Regan Capital’s focus on U.S. mortgage-backed securities, noting the company manages around $3.6 billion across mutual funds, ETFs, and a UCITS ETF for non-U.S. investors. “Mortgages are about $13.5 trillion outstanding,” Weinand said, emphasizing the scale of the U.S. mortgage market and the challenges

en

00:06:40

Standard Uranium maps 2026 growth after strong...

Proactive - Interviews for investors ·

2025/12/17

Standard Uranium CEO Jon Bey joined Steve Darling from Proactive to discuss the company’s operational progress throughout 2025 and outline its strategic roadmap heading into 2026, highlighting a year marked by successful capital raising, advancing exploration programs, and the expansion of its joint venture portfolio. Bey noted that Standard Uranium raised nearly C$7.0 million during 2025, providing the financial foundation to advance multiple exploration initiatives across its project portfolio. A

en

00:04:48

1911 Gold launches 2,200 metre drill program at...

Proactive - Interviews for investors ·

2025/12/17

1911 Gold Corporation Chairman Gary O’Connor joined Steve Darling from Proactive to announce the start of a 2,200-metre diamond drilling program at the Ogama-Rockland gold deposit, located southeast of the company’s True North Gold Project. The program has already commenced, with one surface diamond drill rig mobilized to site. The drilling campaign is designed to support both resource expansion and confirmation, as the company continues to advance its understanding of the Ogama-Rockland deposit

en

00:05:35

BioVie advances Parkinson’s, long COVID, and liver...

Proactive - Interviews for investors ·

2025/12/17

BioVie CEO Cuong Do joined Steve Darling from Proactive to provide an update on the company’s recent progress across its two lead drug candidates, Bezisterim and BIV201, as BioVie positions itself for multiple clinical and regulatory catalysts in 2026. Bezisterim, an anti-inflammatory compound that blocks tumor necrosis factor alpha (TNF-α), is being evaluated across several indications, including Parkinson’s disease, long COVID, and Alzheimer’s disease. Do highlighted that the compound has

en

00:05:14

2025.12.17 Tiziana Life Tiziana Life Sciences doses...

Proactive - Interviews for investors ·

2025/12/17

Tiziana Life Sciences CEO Ivor Elrifi joined Steve Darling from Proactive to announce a key clinical milestone, confirming that the first patient has been successfully dosed with intranasal foralumab in the company’s Phase 2 randomized, placebo-controlled clinical trial in patients with early Alzheimer’s disease (AD). This achievement follows the company’s December 12, 2025 announcement that patient enrollment had begun, with first dosing expected imminently. The rapid progression from enrollment to

en

4,066 results

Similar Podcasts

TaxTalent.com The Golden Rule Podcast

Adam Golden

TaxTalent.com Podcast

Tony Santiago

Handelsblatt Crime - spannende Streitfälle der deutschen Wirtschaft

Ina Karabasz, Solveig Gode, Sönke Iwersen

Deffner und Zschäpitz – Der Wirtschafts-Talk von WELT

WELT

Black Box - La scatola nera della finanza

Guido Brera e Gian Luca Comandini -...